Inventor · disambiguated record
Yusuke Adachi
Also filed as: ADACHI YUSUKE
5 granted patents·7 pending applications·3 citations·filing 2010–2025
66Inventor score
Top patents by PatentIndex Score
12 records- 0175US2023212679A1Method for Predicting Effectiveness of Angiogenesis InhibitorEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 0274US9527921B2Anti human Notch4 antibodyEISAI R&D MAN CO LTD·Filed 2016·Granted Dec 27, 2016·2 cites·29 claims
- 0372US9969812B2Anti human Notch4 antibodyEISAI R&D MAN CO LTD·Filed 2016·Granted May 15, 2018·1 cites·14 claims
- 0467US2020199689A1Method for Predicting Effectiveness of Angiogenesis InhibitorEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 0562US2017191137A1Method For Predicting Effectiveness Of Angiogenesis InhibitorEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 0661US2025177406A1Pharmaceutical composition for treating tumorsEISAI R&D MAN CO LTD·Filed 2023·Application pending·0 cites
- 0760US12305169B2BBB-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted May 20, 2025·0 cites·28 claims
- 0853US2014148483A1Method For Predicting Effectiveness Of Angiogenesis InhibitorEISAI R&D MAN CO LTD·Filed 2012·Application pending·0 cites
- 0952US2025333736A1Bbb-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2025·Application pending·0 cites
- 1050US11752134B2Composition for enhancing cognitive function, composition for remedying anxiety symptoms, and composition for suppressing cerebral atrophyAJINOMOTO KK·Filed 2020·Granted Sep 12, 2023·0 cites·5 claims
- 1138US2021349097A1Biomarkers for a combination therapy comprising lenvatinib and everolimusEISAI R&D MAN CO LTD·Filed 2019·Application pending·0 cites
- 1236US9260500B2Peptide and use thereofASAMI TAIJI·Filed 2010·Granted Feb 16, 2016·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Yusuke Adachi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →